AdaptHealth (AHCO) Net Income towards Common Stockholders (2018 - 2026)

AdaptHealth has reported Net Income towards Common Stockholders for 9 years, with the latest figure at -$132.7 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 939.57% year-over-year to -$132.7 million in Q2 2026; TTM through Jun 2026 was -$223.4 million, a 362.79% decrease from a year earlier, with the FY2025 full-year figure at -$66.1 million, down 169.69% from the prior year.
• Net Income towards Common Stockholders was -$132.7 million for Q2 2026 at AdaptHealth, down from -$14.9 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $51.4 million in Q4 2024, with the low at -$452.9 million in Q3 2023.
• Average Net Income towards Common Stockholders over 5 years is -$40.5 million, with a median of $13.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders jumped 1063.51% in 2022, then tumbled 15729.09% in 2023.
• Over 5 years, Net Income towards Common Stockholders stood at -$1.6 million in 2022, then sank by 15729.09% to -$253.6 million in 2023, then surged by 120.27% to $51.4 million in 2024, then slumped by 297.56% to -$101.6 million in 2025, then plunged by 30.69% to -$132.7 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$132.7 million (Q2 2026), -$14.9 million (Q1 2026), and -$101.6 million (Q4 2025), per Business Quant data.